This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hagens Berman Sobol Shapiro LLP Lawsuit: Fresenius Medical Care And DaVita Healthcare Partners Liable For GranuFlo And NaturaLyte Deaths

The class-action complaints cite two patients who died of cardiac arrest while receiving treatment from DaVita. Stella Nunes, a California resident, suffered a fatal heart attack on Dec. 26, 2012, while receiving dialysis treatment. Jean Thornton, a Wisconsin resident, suffered a fatal heart attack shortly after returning home from treatment at a DaVita clinic in Nov. 2011, according to the lawsuit. The lawsuit claims that these deaths could have been prevented had DaVita properly monitored the bicarbonate levels of its patients and tracked deaths and complications associated with its use of GranuFlo and NaturaLyte.

The lawsuits claim that DaVita is guilty of negligence for failing to protect its patients from the products.

DaVita owns and operates 1,954 outpatient dialysis centers in 44 states throughout the United States.

More information is available at http://www.hbsslaw.com/cases-and-investigations/Fresenius

About Hagens Berman Seattle-based Hagens Berman Sobol Shapiro LLP is a national plaintiff-focused law firm with offices in ten cities. Founded in 1993, we represent plaintiffs in class actions and multi-state, large-scale litigation that seek to protect the rights of investors, consumers, workers, whistleblowers and others. More information about the firm is available at www.hbsslaw.com

Media Contacts

Firmani + Associates Inc. Mark Firmani, 206-443-9357 mark@firmani.com

SOURCE Hagens Berman Sobol Shapiro LLP

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs